• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Edwards Lifesciences (NY: EW )

    86.50 +0.69 (+0.80%)
    Official Closing Price Updated: 7:00 PM EDT, Jul 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,433,950
    Open 87.04
    Bid (Size) 83.83 (1)
    Ask (Size) 89.18 (1)
    Prev. Close 85.81
    Today's Range 85.75 - 87.50
    52wk Range 60.57 - 95.73
    Shares Outstanding 602,400,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024
    From Edwards Lifesciences Corporation
    Via Business Wire
    Edwards Lifesciences to Acquire Innovalve
    From Edwards Lifesciences Corporation
    Via Business Wire

    Performance

    YTD
    +14.46%
    +14.46%
    1 Month
    -2.63%
    -2.63%
    3 Month
    +0.65%
    +0.65%
    6 Month
    +16.40%
    +16.40%
    1 Year
    -6.64%
    -6.64%

    More News

    Read More
    P/E Ratio Insights for Edwards Lifesciences
    Via Benzinga
    UnitedHealth, Edwards Lifesciences, First Citizens Bank And More: CNBC's 'Final Trades'
    Via Benzinga
    $1000 Invested In This Stock 20 Years Ago Would Be Worth $33,000 Today
    Via Benzinga
    The Analyst Landscape: 13 Takes On Edwards Lifesciences
    Via Benzinga
    Peering Into Edwards Lifesciences's Recent Short Interest
    Via Benzinga
    $100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth This Much Today
    Via Benzinga
    Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review
    Via Investor's Business Daily
    Topics Stocks
    Exposures US Equities
    Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
    From Edwards Lifesciences Corporation
    Via Business Wire
    BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences' Critical Care Group: Details
    Via Benzinga
    If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,900 Today
    Via Benzinga
    What Analysts Are Saying About Edwards Lifesciences Stock
    Via Benzinga
    Looking Into Edwards Lifesciences's Recent Short Interest
    Via Benzinga
    Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal
    Via Investor's Business Daily
    Edwards Lifesciences to Sell Critical Care to BD
    From Edwards Lifesciences Corporation
    Via Business Wire
    Here's How Much $1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today
    Via Benzinga
    Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    Is It Time To Get Defensive With Healthcare Stocks?
    Via Talk Markets
    Assessing Edwards Lifesciences: Insights From 11 Financial Analysts
    Via Benzinga
    $1000 Invested In This Stock 15 Years Ago Would Be Worth $16,000 Today
    Via Benzinga
    Jim Cramer: These Airline Stocks 'Trade Wildly,' Edwards Lifesciences 'At The Right Level To Buy'
    Via Benzinga
    Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
    Via Investor's Business Daily
    EW Stock Earnings: Edwards Lifesciences Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff
    Via Investor's Business Daily
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.